FASENRA PEN
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 09 May 2025)
What this means for you
Registered since 31 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88160463
- Registration number
- 5951274
- Mark type
- Stylized text
- Filed
- 18 Oct 2018
- Published for opposition
- 06 Aug 2019
- Registered
- 31 Dec 2019
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and substances for the prevention and treatment of respiratory diseases and disorders
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prior registrations
Prosecution history
- 09 May 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 May 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 May 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Jan 2025 — TEAS SECTION 8 & 15 RECEIVED
- 31 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Jul 2021 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 22 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Jul 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 31 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 26 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Nov 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE